These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17172586)
1. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Zigmond E; Preston S; Pappo O; Lalazar G; Margalit M; Shalev Z; Zolotarov L; Friedman D; Alper R; Ilan Y Gut; 2007 Jan; 56(1):82-9. PubMed ID: 17172586 [TBL] [Abstract][Full Text] [Related]
2. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555 [TBL] [Abstract][Full Text] [Related]
3. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079 [TBL] [Abstract][Full Text] [Related]
4. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
5. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366 [TBL] [Abstract][Full Text] [Related]
6. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Safadi R; Zigmond E; Pappo O; Shalev Z; Ilan Y Int Immunol; 2007 Aug; 19(8):1021-9. PubMed ID: 17698563 [TBL] [Abstract][Full Text] [Related]
7. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Oncology; 2004; 66(4):323-30. PubMed ID: 15218301 [TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387 [TBL] [Abstract][Full Text] [Related]
9. Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization. Ben Ya'acov A; Lalazar G; Livovsky DM; Kanovich D; Axelrod E; Preston S; Schwarzmann G; Ilan Y Mol Immunol; 2009 Dec; 47(2-3):526-33. PubMed ID: 19818503 [TBL] [Abstract][Full Text] [Related]
10. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. Zigmond E; Shalev Z; Pappo O; Alper R; Zolotarov L; Ilan Y J Autoimmun; 2008 Sep; 31(2):188-95. PubMed ID: 18710796 [TBL] [Abstract][Full Text] [Related]
11. Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. Lalazar G; Ben Ya'acov A; Eliakim-Raz N; Livovsky DM; Pappo O; Preston S; Zolotarov L; Ilan Y J Lipid Res; 2008 Sep; 49(9):1884-93. PubMed ID: 18480029 [TBL] [Abstract][Full Text] [Related]
12. Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination. Mizrahi M; Lalazar G; Ben Ya'acov A; Livovsky DM; Horowitz Y; Zolotarov L; Adler R; Shouval D; Ilan Y Vaccine; 2008 May; 26(21):2589-95. PubMed ID: 18423947 [TBL] [Abstract][Full Text] [Related]
13. Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. Livovsky DM; Lalazar G; Ben Ya'acov A; Pappo O; Preston S; Zolotaryova L; Ilan Y Int Immunopharmacol; 2008 Sep; 8(9):1298-305. PubMed ID: 18602077 [TBL] [Abstract][Full Text] [Related]
14. Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. Shuvy M; Hershcovici T; Lull-Noguera C; Wichers H; Danay O; Levanon D; Zolotarov L; Ilan Y World J Gastroenterol; 2008 Jun; 14(24):3872-8. PubMed ID: 18609712 [TBL] [Abstract][Full Text] [Related]
15. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Margalit M; Abu Gazala S; Alper R; Elinav E; Klein A; Doviner V; Sherman Y; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G917-25. PubMed ID: 15976388 [TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045 [TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y J Pathol; 2006 May; 209(1):121-8. PubMed ID: 16482497 [TBL] [Abstract][Full Text] [Related]
18. Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver. Horani A; Shoseyov D; Doron S; Mruwat R; Amer J; Kerem E; Safadi R Immunobiology; 2011 May; 216(5):548-57. PubMed ID: 21074892 [TBL] [Abstract][Full Text] [Related]
19. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. El Haj M; Ben Ya'acov A; Lalazar G; Ilan Y World J Gastroenterol; 2007 Nov; 13(44):5799-804. PubMed ID: 17990345 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking. Gur C; Karussis D; Golden E; Doron S; Ilan Y; Safadi R Clin Immunol; 2006; 118(2-3):307-16. PubMed ID: 16290121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]